Wholesale Inflation Accelerates 6 YearoverYear in April Exceeding Consensus Estimates US Funds Build Cash Reserves Ahead of Anticipated SpaceX and OpenAI Public Listings BJs Wholesale Club Announces Strategic Store Overhaul Amid Consumer Spending Slowdown The Front Row at the Indy 500 Prime Real Estate with Financial Rewards SP 500 MeltUp Scenario Could the Index Reach 8000 or Higher Disneys Star Wars The Mandalorian and Grogu Opens to Weakest Thursday Previews in Series History CRMD Q1 2026 Earnings Profit Surge Driven by NonOperating Items Revenue Remains Absent EQH Q1 2026 Earnings Slightly Misses Estimates on EPS Innoviva Inc INVA Q1 2026 Earnings Significant EPS Miss Amidst Revenue Discrepancy Stock Declines CE Q1 2026 Earnings EPS Misses Estimates by 46 Stock Gains 107 TriplePoint Venture Growth BDC Corp TPVG Q1 2026 Earnings EPS Misses Estimates Amid Venture Debt Market Pressures RELX Q2 2025 Earnings Narrow EPS Beat with Slight Stock Decline Lithium Argentina LAR Surges Over 5 Key Levels in Focus Herbalife HLF Surges 2 Breaking Out of Consolidation or Temporary Relief Leonardo DRS DRS Rides Defense Momentum Testing Key Resistance at 48 CeriBell Inc CBLL Modest Pullback Near Key Support Zone Midland States Bancorp MSBI Edges Lower Amid Quiet Trading Indonesian Commodity Exporters Cite Multiple Obstacles in State Monopoly Proposal GOODO Q1 2026 Earnings Preferred Stock Beats EPS Estimates With 5686 Surprise JELDWEN Holding JELD Edges Higher Approaching Key Resistance Level OppFi Inc Q1 2026 Earnings EPS Beat Drives Positive Stock Reaction MGPI Q1 2026 Earnings Earnings Surge Past Estimates with 308 Surprise Oppenheimer Holdings Inc OPY Q1 2025 Earnings EPS of 272 Reflects Operational Discipline Amid Revenue Uncertainty Enlight Renewable Energy Ltd ENLT Q1 2026 Earnings Positive EPS Surprise Amid Limited Visibility RCB Q1 2026 Earnings EPS Misses Estimates by Wide Margin Bond Price Declines Labcorp Q1 2026 Earnings EPS Tops Estimates by Slim Margin Shares Edge Higher Nkarta Inc NKTX Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline